Kailera Therapeutics Statistics

Total Valuation

KLRA has a market cap or net worth of $3.13 billion. The enterprise value is $2.40 billion.

Market Cap	3.13B
Enterprise Value	2.40B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

KLRA has 123.68 million shares outstanding.

Current Share Class	123.68M
Shares Outstanding	123.68M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	7.82%
Float	63.01M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.79
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 12.01, with a Debt / Equity ratio of 0.02.

Current Ratio	12.01
Quick Ratio	11.83
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -36.90% and return on invested capital (ROIC) is -24.18%.

Return on Equity (ROE)	-36.90%
Return on Assets (ROA)	-22.73%
Return on Invested Capital (ROIC)	-24.18%
Return on Capital Employed (ROCE)	-24.52%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$1.03M
Employee Count	145
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	3,224,675

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-158.34M
Pretax Income	-148.96M
Net Income	-148.96M
EBITDA	-158.03M
EBIT	-158.34M
Earnings Per Share (EPS)	-$7,819.98

Full Income Statement

Balance Sheet

The company has $546.06 million in cash and $10.75 million in debt, with a net cash position of $641.98 million or $5.19 per share.

Cash & Cash Equivalents	546.06M
Total Debt	10.75M
Net Cash	641.98M
Net Cash Per Share	$5.19
Equity (Book Value)	635.91M
Book Value Per Share	-18,713.67
Working Capital	511.13M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$120.21 million and capital expenditures -$2.09 million, giving a free cash flow of -$122.30 million.

Operating Cash Flow	-120.21M
Capital Expenditures	-2.09M
Depreciation & Amortization	310,000
Net Borrowing	100.00M
Free Cash Flow	-122.30M
FCF Per Share	-$0.99

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

KLRA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-4.89%
FCF Yield	-4.02%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1